LTS:0JZU (USA)
Business Description
McKesson Corp
NAICS : 424210
SIC : 5122
6555 State Highway 161, Irving, TX, USA, 75039
Compare
Compare
Traded in other countries / regions
M1CK34.Brazil
•
MCK.Germany
•
MCK.Mexico
•
0JZU.UK
•
MCK.USA
Description
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | -0.03 | |||||
| Debt-to-Equity | -3.71 | |||||
| Debt-to-EBITDA | 2.3 | |||||
| Interest Coverage | 16.42 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.13 | |||||
| Beneish M-Score | -2.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.4 | |||||
| 3-Year EBITDA Growth Rate | 26.3 | |||||
| 3-Year EPS without NRI Growth Rate | 249.5 | |||||
| 3-Year FCF Growth Rate | 12.8 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 3.66 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | 4.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.96 | |||||
| Quick Ratio | 0.55 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 27.62 | |||||
| Days Sales Outstanding | 25.84 | |||||
| Days Payable | 54.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 6.6 | |||||
| 3-Year Average Share Buyback Ratio | 8.6 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 4.89 | |||||
| Operating Margin % | 1.06 | |||||
| Net Margin % | 0.52 | |||||
| ROA % | 2.21 | |||||
| ROIC % | 8.73 | |||||
| ROC (Joel Greenblatt) % | 65.03 | |||||
| ROCE % | 15.38 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 39.21 | |||||
| Forward PE Ratio | 15.65 | |||||
| PE Ratio without NRI | 39.21 | |||||
| Shiller PE Ratio | 78.31 | |||||
| Price-to-Owner-Earnings | 21.97 | |||||
| PS Ratio | 0.21 | |||||
| Price-to-Free-Cash-Flow | 12.14 | |||||
| Price-to-Operating-Cash-Flow | 11 | |||||
| EV-to-EBIT | 22.85 | |||||
| EV-to-EBITDA | 17.98 | |||||
| EV-to-Revenue | 0.22 | |||||
| EV-to-FCF | 12.54 | |||||
| Price-to-Projected-FCF | 1.24 | |||||
| Price-to-Median-PS-Value | 1.2 | |||||
| Earnings Yield (Greenblatt) % | 4.38 | |||||
| Forward Rate of Return (Yacktman) % | -15.93 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 268,446 | ||
| EPS (TTM) ($) | 9.4 | ||
| Beta | 0.83 | ||
| Volatility % | 4.51 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 205.963 | ||
| 12-1 Month Momentum % | 4.2 | ||
| 52-Week Range ($) | 197.6674 - 205.963 | ||
| Shares Outstanding (Mil) | 143.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
McKesson Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||